ABSTRACT. Plasma immunoglobulin concentrations of premature infants of birth weight less than 1500 g were measured longitudinally from birth to 10 months chronological age. Infants were divided into two groups based on gestational age (group I: 25-28 wk; group 11: 29-32 wk). In the 1st wk of life, plasma IgG levels correlated with gestational age ( r = 0.5, p < 0.001). At 3 months chronological age, the geometric mean plasma IgG levels were 60 mg/dl in group I and 104 mg/dl in group I1 infants. Most infants remained hypogammaglobulinemic at 6 months with seven of 11 infants in group I and 13 of 21 infants in group I1 having plasma IgG levels below 200 mgldl. In the 1st wk of life, plasma IgM concentrations were 7.6 and 9.1 mgldl in groups I and 11, respectively. They rose to 41.8 and 34.7 by 8 to 10 months of life. Plasma IgA concentrations were comparable for groups I and I1 in the 1st wk of life (1.2 and 0.6 mg/dl, respectively), but at 1 month of age group I infants had a transient increase in IgA which was not seen in the group I1 infants (4.5 versus 1.9 mgldl, respectively, p < 0.02). This transient elevation in IgA did not correlate with type or route of feeding or amounts of transfused blood. Group I and group I1 infants had comparable rates of infections prior to discharge from the nursery ( p = 0.27). After discharge, the 43 preterm infants followed until 10 months chronological age had a significantly higher incidence of infections than 41 term infants ( p = 0.04). In addition, the preterm infants had more lower respiratory infections after discharge than term infants (14 versus 2, p = 0.003), and were rehospitalized more often for infection (8 versus 0, p = 0.01). Despite severe prolonged hypogammaglobulinemia, none of the preterm infants had bacteremic illness after discharge from the nursery. This study provides normal age-group immunoglobulin values for the first 10 months of life in very small premature infants. The lack of invasive bacterial infections in this small group of preterm infants after discharge from the nursery suggests that further studies will be necessary to determine whether the hypogammaglobulinemia places these very low birth weight infants at risk for serious infection. (Pediatr Res 20:899-904, 1986) Abbreviations VLBW, very low birth weight NICU, Neonatal Intensive Care Unit
logical age, the geometric mean plasma IgG levels were 60 mg/dl in group I and 104 mg/dl in group I1 infants. Most infants remained hypogammaglobulinemic at 6 months with seven of 11 infants in group I and 13 of 21 infants in group I1 having plasma IgG levels below 200 mgldl. In the 1st wk of life, plasma IgM concentrations were 7.6 and 9.1 mgldl in groups I and 11, respectively. They rose to 41.8 and 34.7 by 8 to 10 months of life. Plasma IgA concentrations were comparable for groups I and I1 in the 1st wk of life (1.2 and 0.6 mg/dl, respectively), but at 1 month of age group I infants had a transient increase in IgA which was not seen in the group I1 infants (4.5 versus 1.9 mgldl, respectively, p < 0.02). This transient elevation in IgA did not correlate with type or route of feeding or amounts of transfused blood. Group I and group I1 infants had comparable rates of infections prior to discharge from the nursery ( p = 0.27). After discharge, the 43 preterm infants followed until 10 months chronological age had a significantly higher incidence of infections than 41 term infants ( p = 0.04). In addition, the preterm infants had more lower respiratory infections after discharge than term infants (14 versus 2, p = 0.003), and were rehospitalized more often for infection (8 versus 0, p = 0.01). Despite severe prolonged hypogammaglobulinemia, none of the preterm infants had bacteremic illness after discharge from the nursery. This study provides normal age-group immunoglobulin values for the first 10 months of life in very small premature infants. The lack of invasive bacterial infections in this small group of preterm infants after discharge from the nursery suggests that further studies will be necessary to determine whether the hypogammaglobulinemia places these very low birth weight infants at risk for serious infection. During the 3rd trimester of pregnancy, serum IgG levels increase in the fetus by the transfer of maternal IgG across the placenta (1-4). At birth, IgG levels are directly proportional to gestational age (4, 5) . In a study by Hobbs and Davis (4), nearly all infants 32 wk gestation or less had serum IgG levels below 400 mg/dl at birth, compared with mean levels of approximately 1000 mg/dl in term infants (6) . It was predicted that, since very small premature infants were born with such low levels of IgG, a large proportion of them could develop marked hypogammaglobulinemia (i.e. less than 100 mg/dl) during the first 6 months of life (4), the period when these infants appear to be at the greatest risk of infection (7) (8) (9) .
Recent advances in perinatal and neonatal care have led to survival rates of up to 60 to 70% in VLBW infants (i.e. those born weighing less than 1500 g), and have resulted in a growing number of these infants in pediatricians' practices (10, 11) . VLBW infants have more medical problems and higher rehospitalization and mortality rates than term infants (7, 8) , a result, in part, of an increased incidence and severity of infections (7, 8) . Although several studies (4, 12) have examined the correlation between serum IgG levels and gestational age at birth, none has systematically evaluated IG levels in VLBW infants longitudinally or provided reference values outside of the newborn period. This study was undertaken to describe the ranges of plasma IG levels and the pattern of infection in VLBW infants during the first 10 months of life.
METHODS
Infants enrolled in the study were appropriate for gestational age and were either inborn or transferred within the first 24 h of life to the NICU at the University of Connecticut Health Center. All infants had birth weights of less than 1500 g. Informed written consent was obtained from the parents. Infants with major congenital or metabolic defects or intrauterine infection were excluded from the study. Two babies were excluded after doublevolume exchange transfusions. When blood transfusions were required, tightly packed red blood cells (Hct greater than 80%) resuspended in saline to Hct 50-60% were used in order to reduce the amount of IG in the transfusion. Almost all mothers were mamed, insured, and had 12 or more years of education, 900 BALLOW and fewer than one-fourth smoked. This pattern is consistent with the general newborn population at this institution.
Most infants received hyperalimentation containing 1-2 g/kg protein per day (Freamine 111, American McGraw, Irvine, CA) prior to initiation of enteral feedings. When clinically stable, infants were fed human milk (supplied by their own mother and supplemented with milk from donor mothers of other premature infants as needed), or formula (Similac PM 60140, or Similac Special Special Care, Ross Laboratories, Columbus, OH). Infants less than 1200 g and those who required mechanical ventilation were fed by continuous NJ. The rest were fed by NG. Oral feedings were initiated as tolerated, generally when the infants weighed more than 1500 g.
Seventy-five infants were enrolled in the study. Because the infants reported herein are part of an ongoing study to determine the effects of feeding formula versus human milk on the development of immune system, four infants who developed necrotizing enterocolitis and six who were unable to tolerate enteral feeds by 28 days of life were withdrawn from the study. The remaining 65 infants were followed until discharge from the NICU at a mean of 67 + 2 1 (SD) days chronological age (range 26-125). They were divided into two groups based on gestational age as determined by maternal dates and the method of Dubowitz et al. (13) . Group I consisted of 20 infants 25 to 28 wk gestation (mean f SD birth weight, 864 f 168 g; range 610-1255 gm) and group 11, 45 infants 29 to 32 wk gestation (1250 + 140 g, 985-1485 g). There were six males and 14 females in group I and 29 males and 16 females in group 11. Seventeen infants in group I and 40 in group I1 were Caucasian, two infants in group I and three infants in group I1 were black, one each Hispanic, and one in group I1 was Oriental. There were no deaths in either study group.
Upon discharge from the NICU, infants were seen in the Neonatal Follow-up Clinic at the University of Connecticut Health Center at approximately 4, 6, and 10 months chronological age. Data were collected on infections from 43 infants who were followed for at least the first 10 months of life (14 in group I and 29 in group 11).
ZG determinations. Immunoglobulin determinations were performed on 60 of the 65 infants. Beginning in the 1st wk of life (median = day 6), heparinized blood samples were obtained by heel stick every 2 wk until discharge from the NICU. Thereafter, heparinized blood was obtained by venipuncture at follow-up clinic visits. Plasma was stored at -70" C in small aliquots. Plasma was used instead of serum in this study to allow the recovery of lymphocytes for other studies of the immune system. We have found that IG concentrations in plasma and serum are comparable (Ballowm M, unpublished data). Blood was available for IG measurements in 60 infants for the first 2 months of life, 32 at 6 months, and 22 at 8 to 10 months.
Plasma immunoglobulins G, M and A were measured by an ELISA as previously described (14) . The amounts of isotypespecific IG in the plasma sample were determined by comparison with a standard of human serum (Calbiochem-Behring, La Jolla, CA) with known amounts of IgG, IgM, and IgA. Linear regression analysis of the standard curve was performed, and the amount of IG in the plasma was calculated by polynomial regression. The lower limits of the standard curve were 94 ng/ ml for IgG and IgA and 188 ng/ml for IgM. The interplatel interday coefficient of variation was 13%. The results obtained by ELISA were comparable to those obtained by nephelometry (n = 6, r = 0.89, p < 0.01). The ELISA was used in preference to nephelometry because it is a more sensitive assay, and required much smaller volumes of plasma (10-25 pl) . The values for IgG, IgA, and IgM for each group of infants at various ages were log transformed for statistical analysis and expressed as geometric means. Reference ranges were obtained by taking the antilog of (mean logarithm f 2 SD of the logarithms.) Group comparisons were performed by Student's t test on the log transformed values.
Infections. Information about type and number of infections prior to discharge from the NICU was recorded prospectively for all 65 infants by the study nurse. Data were available on the pattern of infections up to 10 months chronological age for 43 preterm infants. After discharge, the mothers of these infants were interviewed by phone and at each clinic visit by the study nurse for information about infections. Interviews were conducted every 2 wk until the infant reached 4 months chronological age, and at monthly intervals thereafter. Because premature infants have different medical problems and are discharged from the hospital later than term infants, it is impossible to have a true "control" group. However, in order to determine the expected incidence of infection in infants in our community at the time of the study, we enrolled 41 healthy term infants as a comparison group. These children were born at the University of Connecticut Health Center during the study period and followed for patterns of infection for 10 months of life. They were comparable to the preterm study infants with regard to maternal marital and insurance status, education, smoking, and race. Mothers of these term infants were interviewed by telephone when the infants were 2 and 4 wk old, and at monthly intervals thereafter. Information was obtained on type and number of infections. Because preterm infants were not discharged from the nursery until 1 to 4 months of age, the incidence of infections in preterm infants after discharge from the nursery was compared to that in term infants by comparing the number of episodes of infections per patient per month of outpatient follow-up until 10 months chronological age.
RESULTS
ZGs. The plasma IgG concentrations of group I infants from 1 wk to 10 months of age are shown in Figure 1 and Table 1 . The plasma levels of IgG in the 1st wk of life were directly proportional to gestational age (r = 0.5, p < 0.001). The geometric mean plasma IgG level in the 1st wk of life of group I infants was 25 1 mg/dl. Thereafter, levels fell progressively, reaching their lowest point (60 mgldl) at 3 months chronological age, when 11 of 13 infants had plasma IgG levels less than 100 mg/dl. By 6 months of age, the mean IgG level was 159 mg/dl, and seven of 1 1 babies still had IgG levels less than 200 mg/dl. At 8 to 10 months, the mean IgG level rose to 273 mg/dl, and three of six infants studied had levels less than 200 mg/dl.
During the 1st wk of life, the geometric mean plasma IgG concentration of the group I1 infants was significantly higher (368 mg/dl, p < 0.002) than that of group I infants ( Fig. 1 and Table 2 ). In group 11, as in group I infants, mean plasma IgG values were lowest at 3 months chronological age (104 mg/dl), when eight of 14 infants had plasma IgG levels less than 100 mgldl. By 6 months, the mean IgG level was 179 mg/dl, and 13 of 21 infants had levels less than 200 mg/dl. At 8 to 10 months of life, the mean plasma IgG level had risen to 280 mgldl, and only two of 16 infants had levels less than 200 mg/dl.
As shown in Figure 2 and Tables 1 and 2 , the geometric mean plasma IgM concentrations remained comparable ( p > 0.05) for infants in groups I and I1 from the 1st wk of life (7.6 and 9.1 mg/dl, respectively) until age 8 to 10 months (41.8 and 34.7 mg/ dl, respectively.)
The plasma IgA concentrations are shown in Figure 3 and Tables 1 and 2 . In group I infants the mean plasma IgA was very low in the 1 st wk of life (1.2 mg/dl). At 1 and 1.5 months of age the mean plasma IgA rose to 4.5 and 4.3 mg/dl, respectively. At 1.5 months of age, nine of 14 group I infants had elevated plasma levels of IgA (i.e. IgA > 3.0 mg/dl which represents the 99% confidence limits for geometric mean IgA of group I1 infants at 1.5 months of age). Paired plasma samples were available on eight of these nine infants. In these paired samples, the plasma IgA had fallen from a mean (+ 1 SD) of 8.2 (4.0-17.1 mg/dl) at 1.5 months to 2.6 (1.4-4.8) mg/dl at 3 months chronological age (paired t test, p < 0.02). In group I infants as a whole, the geometric mean plasma IgA fell to 3.0 mg/dl at 3 months of age.
In an effort to determine the cause of the transient elevation in t The normal ranges in parentheses were determined by taking the antilog of (mean logarithm f 2 SD of the logarithms).
IgA at 1 to 1.5 months of age, several variables were examined. IgA levels did not correlate with the type (human milk or formula) of feeding (x2, p > 0.05), or the amounts of transfused blood these infants had received ( r = 0.468, p = 0.09). Six of the nine infants with elevated IgA (>3.0 mg/dl), and two of six infants with low IgA were fed by the NJ route ( p > 0.05; x2).
As was seen in group I infants, the mean plasma IgA concentration in group I1 infants was very low at birth (0.6 mg/dl). At 1 and 1.5 months of life, the mean plasma IgA of group I1 infants was significantly lower than that of group I infants (1.9 versus t The normal ranges in parentheses were determined by taking the antilog of (mean logarithm * 2 SD of the logarithms).
4.5 mg/dl, p < 0.02; and 2.2 versus 4.3 mg/dl, respectively, p < 0.005). After 3 months of age the IgA concentration increased steadily in both groups of premature infants, reaching means of 9.5 mg/dl in group I and 20.9 mg/dl in group I1 by 8 to 10 months of life ( p < 0.05).
INFECTIONS
Prior to discharge from the NICU, the 65 preterm infants had 59 episodes of infections (Table 3) . Seventy percent (14 of 20) of Fig. 3 . Plasma IgA levels in very small premature infants (<I500 g) during the first 10 months of life. Open circles are premature infants [25] [26] [27] [28] wk gestation (group I), and closed circles are infants 29-32 wk gestation (group 11). Bars represent geometric mean f 1 SD (***p < 0.001, **p < 0.005, *p < 0.05). Table 3 . Six infants each developed one episode of clinically significant bacteremia between days 3 and 20 of life (median = 11). There was one episode of "probable infection7' in each of 27 infants (1 1 in group I and 16 in group 11). Probable infections were defined as episodes associated with clinical deterioration deemed significant enough by the attending neonatologist to continue parenteral antibiotics for longer than 72 h, despite negative bacterial cultures. The policy in the John Dempsey Hospital is to discontinue antibiotics within 72 h unless infection is strongly suspected. Some of these episodes may have been viral in nature, but viral cultures and serology were not routinely performed. These episodes had no other discernible etiology such as intracranial hemorrhage. From the time of discharge from the nursery to 10 months chronological age, the 43 preterm infants available for follow-up had 134 infections, compared with 130 in the 4 1 term infants. Group I had a mean (+ 1 SD) of 0.36 f 0.23 infections per infant per month after discharge and group I1 had 0.43 a 0.24.
AGE (Months)
The overall incidence of infections in the preterm infants after discharge from the nursery (0.40 f 0.24 infections per infant per month) was significantly higher than that in the 41 term infants (0.32 + 0.14, p = 0.04). As can be seen in Table 3, 14 preterm but only two term infants had lower respiratory infections (pneumonia or bronchiolitis) after discharge ( p = 0.003). In addition, eight of the preterm but none of the term infants were rehospitalized for infections ( p = 0.01), all of which involved the lower respiratory tract. Three of the rehospitalized infants required admission to an intensive care unit, and two infants required mechanical ventilation for culture-documented respiratory syncytial virus pneumonia. At the time of rehospitalization, these infants had plasma IgG concentrations comparable to the mean of their respective group at that chronological age. None had bronchopulmonary dysplasia and their median duration of oxygen (9 days, range 0-21) and ventilator therapy (8 days, range 0-49) in the NICU were comparable to those of the other preterm infants (18, range 0-81; and 6, range 0-60 days, respectively).
There was no difference between rates of infection in preterm infants who were fed breast milk and those who were fed formula. Also, there was no correlation between the use of betmethasone prior to delivery and subsequent pattern of infection in the NICU, nor was there a correlation between rate of infection and the number of years of maternal education, however, only three mothers had less than 12 yr of education. Too few mothers smoked to allow analysis for this variable.
DISCUSSION
Although the number and isotype diversity of surface IG bearing-B lymphocytes are well-developed by 20 wk gestation, normally the fetus synthesizes only negligible amounts of serum or plasma immunoglobulins (1, 2, 15 ). In the last trimester of pregnancy, maternal IgG is transferred across the placenta to the fetus (2, 3) . At birth, full term infants have serum levels of IgG comparable to, or even higher than, maternal levels (2). In contrast, the levels of IgG in premature infants at birth are directly proportional to gestational age (this study, 4, 12, 16) . Since IgM and IgA do not cross the placenta, serum concentrations of these IGs are very low at birth in both term and preterm infants unless the infant has had an intrauterine infection.
Normal reference ranges for plasma or serum IG values for VLBW infants have not been reported beyond the newborn period. Previous studies of serum IG levels in premature infants included larger premature infants (>33 wk gestation) and/or follow-up periods of, at most, only the first few weeks of life (4, 12, 16-1 9) . In this study, we determined normal age-group IgG, IgM, and IgA values for premature infants less than 32 wk gestation for the first 10 months of life. We demonstrated that the plasma IgG levels fell to remarkably low levels between 2 and 4 months of age, reaching less than 100 mg/dl in 83% of group I and 7 1 % of group I1 infants. By 10 months of age, the plasma IgG levels were similar in the two groups of premature infants, but still markedly below the mean of 66 1 mg/dl reported by Stiehm and Fudenberg (6) as well as others (20,2 1) for normal full term infants of the same chronological age.
Berg (17) reported that serum IgM levels in premature infants less than 33 wk gestation were low at birth and remained low for the first 3 wk of life. We confirmed this finding and went on to demonstrate that the premature infants' plasma IgM levels increased gradually becoming comparable to those reported for full term infants by 10 months of age (6, 20, 2 1).
In most other studies, serum IgA has not been detectable at birth in premature infants. Berg (17) found that the majority of infants still had no demonstrable IgA by 3 wk of age. Even full term infants have been reported to have serum IgA concentrations less than 2 mg/dl at birth (3, 6, 20) . However, these studies used techniques which are not as sensitive as the ELISA method used in the present study. We detected plasma IgA during the 1st wk of life in 89% of infants in group I and 82% of those in group 11. IgA levels remained low until 3 months of age. Thereafter, the plasma IgA increased substantially, perhaps due at least in part to antigenic stimulation in the home, particularly the introduction of new foods (22, 23) . By 8 to 10 months of age, the plasma IgA concentrations in both groups had risen to approximately the same level as reported for term infants at comparable ages (6, 20,2 1).
Unlike the group I1 premature infants, group I infants showed a transient rise in plasma IgA at 1 to 1.5 months of age, the etiology of which is unclear. The absence of a similar transient rise of IgA in group I1 infants suggests a physiological or environmental difference between the two groups. Although group I infants received a larger volume of blood transfusions per kg birth weight than did group I1 infants, the blood for transfusion was tightly packed (Hct >80%) and was resuspended in saline to minimize the administration of plasma containing immunoglobulins to these infants. There was no correlation between blood transfusion volume and plasma IgA levels in group I infants. It is possible that the transient increase in plasma IgA seen in group I infants reflects the physiological response of the less mature gut to the initiation of enteral feedings. Our numbers were too small to determine the effects of "feeding problems," and the route (NJ or NG) of feeding on plasma IgA levels. Additional studies will be necessary to elucidate the pathogenesis of these changes in plasma concentrations of IgA in group I infants.
Our finding of a higher rate of all infections ( p = 0.04), lower respiratory tract infections ( p = 0.003), and rehospitalizations for infections ( p = 0.0 I) in preterm than term infants confirms prior studies (7, 8) . The plasma IgG levels in the eight infants with the most serious infections after discharge from the NICU (i.e. those who were rehospitalized) were comparable to those of their respective groups at that age. The number of infants followed for infections after discharge from the nursery was too small to conclude that there was an increased risk of invasive bacterial disease. Nevertheless, the lack of bacteremic illness in these 43 infants, despite prolonged severe hypogammaglobulinemia, may reflect important differences between this population and patients with congenital or acquired immune deficiency who are unable to produce specific antibody. For example, premature infants unlike most patients with immunodeficiency disorders, can make protective levels of specific antibodies in response to immunization with tetanus and diphtheria toxoids (24, 25) . Thus, despite the severe hypogammaglobulinemia, premature infants mav have humoral immune resDonses which are adeauate to protect against invasive disease from many organisms.
The introduction of intravenous immune serum globulin has made it possible to provide therapy to boost plasma IgG levels in premature infants. The clinical benefits of long-term intramuscular y-globulin prophylaxis in premature infants are unclear (26, 27) . To date, no reports of safety or efficacy on the prophylactic use of intravenous immune serum globulin are available in premature infants. Thus, the routine use of immune serum globulin must await controlled clinical trials to determine both the benefits and adverse effects of such therapy. Although the number of infants followed after discharge were too small to determine the risk of serious invasive bacterial disease, our studies suggest that hypogammaglobulinemia alone may not prove to be an indication for therapy with immune serum globulin.
